Response to Nagasaka et al: Ketoacidosis-onset type 2 diabetes: clinical features and implicatio

Lebovitz, Harold E; McFarlane, Samy; Banerji, Mary Ann

doi:10.2337/diacare.21.8.1377

Article navigation

Letters: Comments and Responses| August 01 1998

Response to Nagasaka et al: Ketoacidosis-onset type 2 diabetes: clinical features and implicatio

Harold E Lebovitz, MD;

Harold E Lebovitz, MD

State University of New York-Health Science Center at Brooklyn

Brooklyn, New York

Search for other works by this author on:

This Site

PubMed

Google Scholar

Samy McFarlane, MD;

Samy McFarlane, MD

State University of New York-Health Science Center at Brooklyn

Brooklyn, New York

Search for other works by this author on:

This Site

PubMed

Google Scholar

Mary Ann Banerji, MD

State University of New York-Health Science Center at Brooklyn

Brooklyn, New York

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Harold E. Lebovitz, MD, State University of New York-Health Science Center at Brooklyn, 450 Clarkson Ave., Brooklyn, NY 11203.

Diabetes Care 1998;21(8):1377–1378

https://doi.org/10.2337/diacare.21.8.1377

Response to Nagasaka et al: Ketoacidosis-onset type 2 diabetes: clinical features and implicatio

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Response to Nagasaka et al: Ketoacidosis-onset type 2 diabetes: clinical features and implicatio

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only